Generalidades sobre el abordaje medico de la Colitis Ulcerosa
Resumen
Palabras clave
Texto completo:
PDFReferencias
Garud Sagar and Peppercorn-Mark A. Ulcerative colitis: current treatment strategies and future prospects. Therapeutic Advances in Gastroenterology 2009.
Kornbluth Asher, Sachar David. Ulcerative Colitis Practice Guidelines in adults: American Collage of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2010;105:501-523.
Gomollón-García Fernando y García-López Santiago. Evidencia científica en colitis ulcerosa. Madrid, Internacional Marketing & Communication, S.A. 2006.
Baumgart Daniel C., Sandborn William J. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007; 369: 1641–57. [ Links ]
García Betanzos Rafael. Enfermedad Inflamatoria Intestinal. Guías Clínicas 2007;7 (27). http://www.fisterra.com/guias2/eii.asp.
Bernstein-Charles N, Fried Michael, Krabshuis JH, Cohen Henry, Eliakim R, Fedail Suleiman, Gearry Richard, Goh KL, Ha-mid Saheed, Aamir-Ghafor Khan, LeMair AW, Malfertheiner-Ouyang Qin, Rey JF, Sood Ajit, Steinwurz Flavio, Thomsen-Ole O, Thomson Alan and Watermeyer Gillian. World Gastroenterology Organization Practice Guidelines for the Diagnosis and Management of IBD in 2010. Inflamm Bowel Dis 2010; 16: 112-124.
Jowett S, Seal C, Pearce M, Phillips E, Gregory W, Barton JR, Welfare MR. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut. 2004 Oct;53(10):1479-84.
González, M. De Ascencao M. Síndrome de intestino irritable. Aspectos psicológicos. Revista de la Facultad de Medicina. 2005; 28(2): 139-145
Yamamoto Furusho Jesús Kazuo. Tratamiento de la enfermedad inflamatoria intestinal. Rev Gastroenterol Mex, 2008; 73 (Supl. 2).
Afif Waqqas, Leighton Jonathan A, Hanauer Stephen B, Loftus Edward V Jr, Faubion William A, Pardi Darrell S, Tremaine William J, Kane Sunanda V, Bruining David H, Cohen Russell D, Rubin David T, Hanson Karen A, and Sandborn William J. Open-Label Study of Adalimumab in Patients with Ulcerative Colitis Including Those with Prior Loss of Response or Intolerance to Infliximab. Inflamm Bowel Dis. September 2009; Volume 15, Number 9.
DOI: http://dx.doi.org/10.61155/gen.v65i2.278
VIDEOS GEN
Autor: Dr. Freddy Pereira Graterol
CPRE. Sitio de sección del ducto pancreático principal | Drenaje transgástrico de pseudoquiste pancreático | CPRE. Sección del ducto hepático izquierdo por traumatismo de abdomen |
Autora: Dra. Anais Karina García Yaraure
Cavernomatosis portal Pre Colocacion de TIPS. | Cavernomatosis portal Post Colocacion de TIPS. |
Revista GEN
ISSN: 0016-3503 e-ISSN: 2477-975X